<p>Rats were treated with L-DOPA once daily for 7 days and the brains were quickly harvested for immunofluorescence staining of pCREB expression (A). The number of pCREB positive cells (n = 6 per group) was determined (B). The number of pCREB positive cells in L-DOPA treated groups was markedly larger than that in CG group. *P<0.05 vs. CG group.</p
The dopamine (DA) precursor L-DOPA remains the most common treatment for Parkinson's disease (PD). H...
The development of L-DOPA-induced dyskinesia (LID) is attributed to plastic responses triggered by d...
Levodopa (L-dopa) is the most widely used agent for the symptomatic relief of Parkinson’s disease. T...
<p>PC12 cells were treated with L-DOPA at different concentrations for 3 days, and PCREB protein exp...
<p>Rats were treated with L-DOPA at different concentrations (0, 30 60 and 120 mg/kg) once daily for...
<p>The 6-OHDA-lesioned hemi-parkinsonian rats were treated with L-DOPA/carbidopa treatment (50/5 mg/...
<p>PC12 cells were treated with L-DOPA at different concentration for 3 days, and CD39 protein expre...
This study aimed to investigate the influence of low-dose levodopa (L-DOPA) on neuronal cell death u...
<p>Confocal laser-scanning microscopic images of double immunofluorescein staining of L-DOPA (Alexa ...
<p>The 6-OHDA-lesioned hemi-parkinsonian rats were treated with L-DOPA/carbidopa treatment (50/5 mg/...
The potential neuroprotective or neurotoxic effects of 3,4-dihydroxyphenylalanine (L-DOPA) are yet t...
<p>PC12 cells were treated with 0, 1, 5, 10, 20, 30, 40 and 50 µmol/L L-DOPA for 3 days with or with...
OBJECTIVE: This study aimed to investigate the influence of low-dose levodopa (L-DOPA) on neuronal c...
Current knowledge of the molecular changes induced by dopamine denervation and subsequent treatment ...
The effect of L-dopa on rat brain protein synthesis was examined by studying the effect of the drug ...
The dopamine (DA) precursor L-DOPA remains the most common treatment for Parkinson's disease (PD). H...
The development of L-DOPA-induced dyskinesia (LID) is attributed to plastic responses triggered by d...
Levodopa (L-dopa) is the most widely used agent for the symptomatic relief of Parkinson’s disease. T...
<p>PC12 cells were treated with L-DOPA at different concentrations for 3 days, and PCREB protein exp...
<p>Rats were treated with L-DOPA at different concentrations (0, 30 60 and 120 mg/kg) once daily for...
<p>The 6-OHDA-lesioned hemi-parkinsonian rats were treated with L-DOPA/carbidopa treatment (50/5 mg/...
<p>PC12 cells were treated with L-DOPA at different concentration for 3 days, and CD39 protein expre...
This study aimed to investigate the influence of low-dose levodopa (L-DOPA) on neuronal cell death u...
<p>Confocal laser-scanning microscopic images of double immunofluorescein staining of L-DOPA (Alexa ...
<p>The 6-OHDA-lesioned hemi-parkinsonian rats were treated with L-DOPA/carbidopa treatment (50/5 mg/...
The potential neuroprotective or neurotoxic effects of 3,4-dihydroxyphenylalanine (L-DOPA) are yet t...
<p>PC12 cells were treated with 0, 1, 5, 10, 20, 30, 40 and 50 µmol/L L-DOPA for 3 days with or with...
OBJECTIVE: This study aimed to investigate the influence of low-dose levodopa (L-DOPA) on neuronal c...
Current knowledge of the molecular changes induced by dopamine denervation and subsequent treatment ...
The effect of L-dopa on rat brain protein synthesis was examined by studying the effect of the drug ...
The dopamine (DA) precursor L-DOPA remains the most common treatment for Parkinson's disease (PD). H...
The development of L-DOPA-induced dyskinesia (LID) is attributed to plastic responses triggered by d...
Levodopa (L-dopa) is the most widely used agent for the symptomatic relief of Parkinson’s disease. T...